Research article summary (published 11 Aug 2003):

Long-term use of hydroxyurea for sickle cell anemia.

Full Abstract

No abstract is currently available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Hagar, Ward (W);

Journal and publication information

Publication Type: Comment; Letter

Journal: JAMA : the journal of the American Medical Association (JAMA), published in United States. (Language: eng)

Reference: 2003-Aug; vol 290 (issue 6) : pp 753; author reply 754

Dates: Created 2003/08/13; Completed 2003/08/18; Revised 2006/11/07;

PMID: 12915424, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: JAMA. 2003 Apr 2;289(13):1645-51. (PMID: 12672732)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Anemia, Sickle Cell - blood; complications; drug therapy Antisickling Agents - therapeutic use Fetal Hemoglobin - metabolism Humans

Hydroxyurea - therapeutic use Leukocyte Count Reticulocyte Count Substance-Related Disorders - complications

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Antisickling Agents (0) ; Hydroxyurea (127-07-1) ; Fetal Hemoglobin (9034-63-3)

Related articles

These are the most related articles currently in our database:

• Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell disease. 30 Dec 2006
• Sickle cell anemia with systemic lupus erythematosus: response to hydroxyurea therapy. 29 Jun 1998
• Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. 29 Sep 1996
• Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. 29 Jun 1997
• Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. 29 Sep 2000
• Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. 30 Dec 2001
• Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy. 30 Dec 2002
• Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy. 30 Oct 2005
• Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. 13 May 1992

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.